Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease
Contenu
Click for External Resource*
Click to read full article*
*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.
Files for Download
http://repository.netecweb.org/pdfs/civ395.pdf
Item Type
PublicationTerms of Use
By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.
Voir les documents
Titre
Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease
Sujet
Description
From 2014 to May 2015, >26 000 Ebola virus disease (EVD) cases were reported from West Africa.
Créateur
Date
2015-09-15
Type
Citer ce document
Florescu, D. F., A. C. Kalil, A. L. Hewlett, A. J. Schuh, U. Stroher, T. M. Uyeki and P. W. Smith (2015). "Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease." Clin Infect Dis 61(6): 969-973.
Résumé
From 2014 to May 2015, >26 000 Ebola virus disease (EVD) cases were reported from West Africa. We present a patient with EVD who received brincidofovir and convalescent plasma. The relative contributions of supportive care, investigational therapies, and patient's immune-response on survival could not be determined. Randomized trials are needed.
Accessibilité
free online - Oxford Academic
Was this resource helpful?